Improving the yield of rAAV manufacturing with HeLa producer cells lines to ensure patient access

Cell & Gene Therapy Insights 2021; 7(8), 1127–1130

10.18609/cgti.2021.148

Published: 5 October 2021
Editorial
Matthew Fuller

“As gene therapy’s successes continue to grow, and as we learn more about the application of this modality, the opportunity to extend it applications to larger footprint diseases becomes feasible.”